A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes
Veeral Ajmera(University of California San Diego), Rohit Loomba(University of California San Diego), Scarlett Lopez(University of California San Diego), Claude B. Sirlin(University of California San Diego), Kaleb Tesfai(University of California San Diego), Ricki Bettencourt(University of California San Diego), Cynthia Behling, Karen Cadman(University of California San Diego), Sandra Cepin(University of California San Diego), Egbert Madamba(University of California San Diego), Lisa Richards(University of California San Diego), Heather Hofflich(University of California San Diego)
Cited by 310
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k